Results 141 to 150 of about 51,349 (223)

Severity of Clinical Presentation and Outcomes in Hospitalized Adult People With Influenza by Type and Subtype, United States-2017-2020. [PDF]

Clin Infect Dis
Cleary S, Lewis NM, Talbot HK, Zhu Y, Martin ET, Monto AS, Gaglani M, Murthy K, Zimmerman RK, Silveira FP, Tenforde MW, Patel MM, Ellington S, Olson SM.   +13 more
europepmc   +1 more source

Fatal human H3N8 influenza virus has a moderate pandemic risk. [PDF]

PLoS Pathog
Le Sage V, Vu MN, Maltepes MA, Wang S, Snow BA, Merrbach GA, Benton AJ, Zirckel KE, Petnuch SE, Marble CN, Rigatti LH, Paulson JC, Drapeau EM, McElroy AK, Hensley SE, Moncla LH, Lakdawala SS.   +16 more
europepmc   +1 more source

Accumulation of Quinolinic Acid Modulates the Pulmonary Immune Response During Influenza Infection. [PDF]

Int J Tryptophan Res
Pamart G, Hennart B, Ollivier A, Kervoaze G, Pichavant M, Gosset P, Le Rouzic O, Poulain-Godefroy O.   +7 more
europepmc   +1 more source

Postinfluenza A(H3N2) refractory invasive pulmonary aspergillosis

Journal of the Formosan Medical Association, 2017
Ku, Yee-Huang, Chuang, Yin-Ching, Yu, Wen-Liang   +2 more
openaire   +3 more sources

Assessment of hemagglutinin-inhibition activity following influenza vaccination during the 2022-2023, 2023-2024, and 2024-2025 seasons. [PDF]

PLoS One
Berber E, Hanley HB, Gamez BM, Ross TM.
europepmc   +1 more source

Surveillance and cross-species transmission assessment of H3NX avian influenza viruses isolated in Guangdong province, China from 2023 to 2025. [PDF]

Poult Sci
Liu J, Xiang HY, Liu J, Li YG, Liang X, Yang Q, Xie J, Gao Y, Ge Y.   +8 more
europepmc   +1 more source

Evolutionary patterns of pH1N1 and H3N2 in relation to vaccine use. [PDF]

BMC Genomics
Lin YW, Guo LZ, Tsai YT, Chu YC, Lin YF, Takemura K, Huang CH, Chang HH, Lee CS.   +8 more
europepmc   +1 more source

Reduced neutralising antibody responses against emerging 2025/26 influenza A(H1N1)pdm09 subclade D.3.1 and A(H3N2) subclade K viruses among healthcare workers, Finland, August to October 2025. [PDF]

Euro Surveill
Ikonen N, Haveri A, Lindh E, Liedes O, Vara S, Pakkanen SH, Kantele A, Nieminen T, Anttila VJ, Välimaa H, Melin M, Savolainen-Kopra C, Nohynek H.   +12 more
europepmc   +1 more source

Adaptation of the multiplexed CRISPR-Cas13 CARMEN RVP assay for longitudinal detection of respiratory pathogens from air samples. [PDF]

Appl Environ Microbiol
Ellis AL, Stauss M, Barros Tiburcio P, Emmen IE, Edlefsen PT, Kosmider E, Barlow S, Goss M, Temte JL, Stachler E, McMahon K, Sabeti P, O'Connor DH, O'Connor SL.   +13 more
europepmc   +1 more source

Is the emerging influenza A(H3N2) K subclade a specific threat for older adults? [PDF]

Geroscience
Quarleri J, Delpino MV.
europepmc   +1 more source